Dimensional Fund Advisors’s CASI Pharmaceuticals CASI Stock Holding History

Dimensional Fund Advisors’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,508	Closed	-$26.5K	–	3489
2023 Q1	$26.5K	Buy	+11,508	New	+$22.2K	﹤0.01%	3425
2022 Q3	$30K	Sell	11,508 -1,697	-13%	-$5.46K	﹤0.01%	3446
2022 Q2	$38K	Sell	13,205 -5	-0%	-$22	﹤0.01%	3417
2022 Q1	$107K	Hold	13,210	–	–	﹤0.01%	3384
2021 Q4	$106K	Sell	13,210 -3,214	-20%	-$32K	﹤0.01%	3433
2021 Q3	$195K	Sell	16,424 -11,010	-40%	-$149K	﹤0.01%	3352
2021 Q2	$425K	Buy	27,434 +1,197	+5%	+$20.1K	﹤0.01%	3196
2021 Q1	$630K	Buy	26,237 +23,208	+766%	+$652K	﹤0.01%	3098
2020 Q4	$89K	Buy	+3,029	New	+$65.8K	﹤0.01%	3283
2015 Q2	–	Sell	-1,690	Closed	-$25K	–	3365
2015 Q1	$25K	Sell	1,690 -447	-21%	-$7.04K	﹤0.01%	3321
2014 Q4	$28K	Hold	2,137	–	–	﹤0.01%	3403
2014 Q3	$38K	Hold	2,137	–	–	﹤0.01%	3417
2014 Q2	$38K	Hold	2,137	–	–	﹤0.01%	3459
2014 Q1	$39K	Hold	2,137	–	–	﹤0.01%	3469
2013 Q4	$37K	Hold	2,137	–	–	﹤0.01%	3440
2013 Q3	$37K	Sell	2,137 -68	-3%	-$1.29K	﹤0.01%	3461
2013 Q2	$45K	Buy	+2,205	New	+$42.8K	﹤0.01%	3447

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors's CASI Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of CASI Pharmaceuticals (CASI) in Q2 2023, closing a stake of 11,508 shares — an estimated $26.5K sold.

Dimensional Fund Advisors first reported a position in CASI in Q2 2013 and held it in 17 quarters. The position peaked at $630K in Q1 2021. 19 funds tracked by Wall St. Rank hold CASI as of Q2 2023.

Dimensional Fund Advisors reported no remaining CASI Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Dimensional Fund Advisors sold 11,508 CASI Pharmaceuticals shares in Q2 2023, an estimated $26.5K.
Dimensional Fund Advisors first reported a position in CASI Pharmaceuticals in Q2 2013 and held it in 17 quarters.
Dimensional Fund Advisors's CASI Pharmaceuticals position peaked at $630K in Q1 2021.
19 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.